The Vela Board would like to express its thanks to SGSC16 Sep 2021 22:30
The Vela Board would like to express its thanks to SGSC for helping to facilitate the placing of its existing shares and acknowledges the support shown in the Company by those existing and new investors who have acquired these shares.
We understand from SGSC that, following the successful results of the ARCADIA trial released last week, it has begun commercial discussions with potential licensees of AZD1656 and will be using the proceeds from the sale of its Vela shares to develop several new innovative-drug programmes.